Biogen signals beyond the news: 42+ signals from 4 sources
The latest Biogen signal on this page is from Sep 29, 2026 (Patents): "BIOGEN MA INC.'s patent output is accelerating: 19 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), YouTube (11) and LinkedIn (9).
Public (BIIB)Biotechnology Research10,000+ employeesbiogen.comLinkedIn
- Signals
- 42+
- Sources
- 4
- Last 90 days
- 22
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Biogen signals by source
42+ signals for Biogen across 4 sources.
Patents · Patent pace
BIOGEN MA INC.'s patent output is accelerating: 19 grants in the past year, 2 in the past 30 days.
Over the past year BIOGEN MA INC. received 19 US patent grants; the recent pace (6 in 90 days) is accelerating versus its trailing baseline.
- Grants, 12 months
- 19
- Grants, 90 days
- 6
- Grants, 30 days
- 2
- Pace
- Accelerating
Patents · Patent grant
Biogen was granted a patent for compounds that degrade BTK.
In September 2026 Biogen patented drug candidates designed to remove Bruton's tyrosine kinase in cells, for potential use in targeted pharmaceutical treatments.
- Patent title
- Compounds for targeting degradation of Bruton's tyrosine kinase
- Grant date
- Sep 29, 2026
- Inventors
- Kevin M. Guckian, Eric Stefan, Corey Don Anderson, Jae Young Ahn
Patents · Patent grant
Biogen was granted a patent for anti-VLA-4 antibodies.
In September 2026 Biogen patented antibody-based compounds designed to bind alpha-4 integrin for potential therapeutic use in medicine.
- Patent title
- Anti-VLA-4 antibodies
- Grant date
- Sep 15, 2026
- Inventors
- Alexey A. Lugovskoy, Frederick R. Taylor, Karen McLachlan
Glassdoor · Poor work life balance
Work life balance is challenging at times for employees
Several employees across different roles mention that work-life balance is difficult at times, with one noting high stress levels are likely.
- Overall rating
- 3.7 of 5
- CEO approval
- 59%
- Reviews read
- 10
- Review window
- Aug 18, 2026 to Sep 9, 2026
Glassdoor · High culture praise
Employees praise inclusive and collaborative culture with strong team members
Multiple reviewers highlight a positive and supportive culture, praising colleagues, inclusion, and collaboration as significant strengths of the company.
- Overall rating
- 3.7 of 5
- CEO approval
- 59%
- Reviews read
- 10
- Review window
- Aug 18, 2026 to Sep 9, 2026
Glassdoor · Growth opportunities
Employees report slow promotions and challenging career advancement paths
Multiple reviewers across different roles and tenures describe difficulties in getting promoted, citing manager dependence and unclear advancement criteria as key obstacles.
- Overall rating
- 3.7 of 5
- CEO approval
- 59%
- Reviews read
- 10
- Review window
- Aug 18, 2026 to Sep 9, 2026
YouTube
For Sneezing Watery Eyes and Fever Biogen no 14 Dr Masood Homoeopathic Pharma product#shorts
Biogen presents a homoeopathic product for sneezing, watery eyes, and fever.
- Channel
- Dr. Tania official
- Views
- 10
- Comments
- 0
- Tags
- Product Information, Homoeopathic Medicine
YouTube
Apellis Q1 Preview: Biogen Deal Closing Soon
Apellis preview focuses on Q1 earnings and potential closing of the Biogen acquisition.
- Channel
- Fazen Markets
- Views
- 0
- Comments
- 0
- Tags
- Acquisition, Earnings Report, Healthcare
LinkedIn
Biogen scientists aim to transform patient lives through groundbreaking science in neurology, immunology, and rare diseases.
Every day, our scientists pursue a simple but powerful mission: to help transform the lives of patients through groundbreaking science. Our teams work across a broad spectrum of disease areas in neurology, immunology, and rare disease. Learn more about our Research and Development organizations and how we’re making...
- Likes
- 94
- Comments
- 3
- Tags
- Product Development, Medical Research, Research & Development
- Initiatives
- advancing scientific research and development
LinkedIn
Biogen thanks attendees and discusses motor neuron protection at the 5th SMA Scientific Congress.
As the 5th International Scientific Congress on spinal muscular atrophy (SMA) draws to a close tomorrow, we would like to thank the healthcare professionals, partners and the patient community who connected with us. This year, discussions focused on motor neuron protection and its potential role in informing...
- Likes
- 176
- Comments
- 3
- Tags
- Medical Research
Showing 10 of 42+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Biogen with the Signal API
One POST /v1/companies/enrich call with biogen.com returns Biogen signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "biogen.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Biogen other signals
What signals does Autobound track for Biogen besides news and filings?
What are people saying about Biogen online?
What do employees say about working at Biogen?
Has Biogen been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .